Gut Microbiome Alterations Could Provide Insight Into Type 2 Diabetes Risk

What if we could detect type 2 diabetes (T2D) years before it develops?

According to the World Health Organization, approximately 830 million people worldwide have diabetes, over 95% of which have T2D. Over time, the condition can lead to blindness, cardiovascular issues, and kidney problems.

While previous studies have documented changes in the gut microbiome of those with T2D, a new comprehensive study led by researchers at Chalmers University of Technology suggests that these changes could be detected years before the disease develops.

One of the study authors, Dr. Gaël Toubon, a postdoctoral researcher in food science at Chalmers’ Department of Life Sciences, believes that the microbiome “could provide additional biological information that complements traditional risk factors, potentially helping identify people at risk earlier or more precisely.”

Previous research has shown that individuals with T2D have reduced gut microbial diversity and a lower abundance of butyrate-producing bacteria. These microbes fuel gut cells, reinforce the intestinal barrier to prevent "leaky gut", and regulate inflammation.

Gut bacteria linked to future diabetes risk

Exploring why the gut microbiome is of interest in T2D research, Toubon said: “The gut microbiome responds to long-term dietary and lifestyle exposures while also influencing key biological processes involved in metabolic health, such as nutrient metabolism, inflammation, and immune function. Although it is generally resilient and recovers from short-term perturbations, persistent changes in its composition may contribute to the gradual development of T2D.”

In the study, the researchers analyzed metagenomic data from 4,685 Swedish participants, who were followed for a median of 5.3 years. 383 of those participants developed T2D in that time.

The team identified six species of bacteria associated with a higher future risk of T2D: Desulfovibrio piger, Alistipes communis, Alistipes finegoldii, Akkermansia muciniphila (A. muciniphila), Ruminococcus gnavus, and GGB3614_SGB4886.

They also identified three species associated with a lower risk of T2D: Coprococcus catus (a butyrate-producing bacterium), an Erysipelotrichaceae bacterium, and Clostridia unclassified SGB6317.

A. muciniphila is often considered a marker of good health. “One of our most interesting findings was that the association between A. muciniphila and future diabetes risk varied according to dietary fiber intake.” Toubon said.

The researchers found that the relationship between A. muciniphila and T2D risk was strongest among participants with the lowest fiber intake, suggesting that when fiber intake is too low, the bacterium may start to break down the gut’s protective mucus layer, leading to inflammation and other metabolic disruptions linked to insulin resistance and T2D.

According to Toubon, this finding highlights the difficulty of microbiome research: “The gut microbiome is a complex ecosystem and the effects of a microbe depend on the surrounding microbial community, the host, diet, and the stage of disease.”

“Gut microbes do not act in isolation and their relationship with health also depends on the surrounding dietary context, which could have important implications for personalized nutrition,” he said.

Toubon indicated that diet is likely the strongest influence on the gut microbiome, and identified “medication use, especially antibiotics, smoking, alcohol consumption, and physical inactivity” as other important factors shaping microbial composition.

DMPK Playbook: Complete Workflows Not Workarounds

This eBook explores key challenges and solutions across metabolite identification, bioanalysis, and tissue distribution, highlighting complete workflow approaches.
View eBook

Advertisement

The future of diabetes risk prediction

Toubon stressed that microbiome-based risk prediction is not yet ready for routine clinical use.

Before such tools could complement established risk factors such as obesity, family history, and blood glucose measurements, he said that "findings need to be replicated in diverse populations, standardized methods are needed, and we must demonstrate that microbiome-based prediction improves clinical decision-making beyond existing tools."

In the paper, the researchers note that the participants of the study had an average age of nearly 74 years, meaning the results will need to be validated in younger and more ethnically diverse populations.

If the results are validated in larger, more diverse studies, the microbiome could become a target for personalized preventive strategies, helping to identify people at risk of developing T2D before conventional symptoms emerge and informing tailored dietary and lifestyle interventions.

Reference: Toubon G, Boulund F, Escobedo CM, et al. Gut microbiome composition and functional potential associate with incident type 2 diabetes in 4,685 adults from a Swedish prospective cohort. Cell Rep Med. 2026;7(6). doi: 10.1016/j.xcrm.2026.102835

About the interviewee:

Dr. Gaël Toubon is a postdoctoral researcher at Chalmers University of Technology and Karolinska Institutet. His current research emphasizes data-driven approaches to understanding human health. His expertise spans metagenomic data processing, bioinformatics, epidemiology, and large-scale cohort data management. Proficient in statistical modeling and machine learning, he brings data to life to elucidate the complex relationships between the gut microbiome and human health.